Cardiovascular diseases represent one of the leading causes of death worldwide. Among the risk factors is dyslipidemia, giving rise to the need for analysis of plasma atherogenic index. The aim of this study was to evaluate the association between atherogenic indices and the presence of coronary risk in adults living in Chile, compared to the independent use of lipid profile components, according to data published in the National Health Survey 2016–2017.
Methods
Secondary analysis study, using the database of the National Health Survey 2016–2017, adults between 18 and 60 years old, both sexes and with a diagnosis of dyslipidemia were selected. Castelli Index I and II atherogenic indices, atherogenic index and atherogenic coefficient were calculated. Spearman's coefficient was used for statistical analysis.
Results
There is a stronger association between atherogenic index, and the presence of cardiovascular risk compared to the independent use of lipid profile components. Plasma atherogenic index (PAI) has the strongest association and is therefore the best predictor of cardiovascular risk.
Conclusion
The use of PAI can be considered a simple, convenient, non-invasive, and inexpensive tool for the early detection of cardiovascular disease in the Chilean population and may help to prevent complications in chronic diseases.
LindstromMDeCleeneNDorseyH, et al.Global burden of cardiovascular diseases and risks collaboration, 1990–2021. J Am Coll Cardiol2022; 80: 2372–2425.
2.
MartinSSAdayAWAlmarzooqZI, et al.2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation2024; 149: e347–e913.
3.
Centers for Disease Control and Prevention. National Center for Health Statistics Mortality Data on CDC WONDER. 2024. Available from: Link.
4.
Londoño AgudeloE. Chronic diseases and the unavoidable transformation of health systems in Latin America. Rev Cuba Salud Pública2017; 43: 68–74.
5.
Pan American Health Organization. Overweight affects almost half of the population of all the countries of Latin America and the Caribbean except for Haiti. 2017. Available from: Link.
6.
National Institute of Statistics of Chile (NIS). Annual Environment Report: 2019. Available from: Link
7.
DagenaisGRLeongDPRangarajanS, et al.Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet2020; 7: 785–794.
Jebari-BenslaimanSGalicia-GarcíaULarrea-SebalA, et al.Pathophysiology of atherosclerosis. Int J Mol Sci2022; 23: 1–38.
10.
LiYWKaoTWChangPK, et al.Atherogenic index of plasma as predictors for metabolic syndrome, hypertension, and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep2021; 11: 1–8.
11.
ShinHRSongSChoJA, et al.Atherogenic Index of plasma and its association with risk factors of coronary artery disease and nutrient intake in Korean adult men: the 2013–2014 KNHANES. Nutrients2022; 14: 1071.
12.
LiuZZhangLWangL, et al.The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study. Cardiovasc Diabetol2024; 23: 264.
13.
AfsinAKayaHSunerA, et al.Plasma atherogenic indices are independent predictors of slow coronary flow. BMC Cardiovasc Disord2021; 21: 1–9.
14.
SasikalaTGoswamiK. Castelli risk index-1 and atherogenic coefficient are better predictors of cardiometabolic risk in patients with hypothyroidism. Int J Clin Biochem Res2020; 7: 254–259.
15.
KazemiTHajihosseiniMMoossaviM, et al.Cardiovascular risk factors and atherogenic indices in an Iranian population: birjand east of Iran. Clin Med Insights Cardiol2018; 12.
16.
von ElmEAltmanDEggerM, et al.The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol2008; 61: 344–349.
17.
Undersecretary of Public Health - Ministry of Health. Technical Orientation Cardiovascular Health Program. Chile: 2017.
18.
SajjaAParkJSathiyakumarV, et al.Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Netw Open2021; 4: 1–14.
19.
WeirCBJanA. BMI classification percentile and cut off points. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025 Jan. PMID: 31082114.
20.
Undersecretary of Public Health - Ministry of Health. Clinical Guideline: Primary or Essential Hypertension In Persons 15 Years and Older. 2010.
21.
National Cholesterol Education Program (NCEP). Executive summary of the third report of the national cholesterol education programme. JAMA2001; 285: 2486–2497.
22.
De la Torre-CisnerosKAcosta-RodríguezZAragundi-IntriagoV. Utilidad clínica de los índices aterogénicos para valoración de riesgo cardiovascular: un enfoque desde el laboratorio clínico. Dominio las Ciencias2019; 5: 57.
23.
Fernández-MacíasJCOchoa-MartínezACVarela-SilvaJA, et al.Atherogenic Index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res2019; 50: 285–294.
24.
LiZHuangQSunL, et al.Atherogenic index in type 2 diabetes and its relationship with chronic microvascular complications. Int J Endocrinol2018; 2018.
25.
HamzehBPasdarYMirzaeiN, et al.Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran. Lipids Health Dis2021; 20: 1–10.
26.
BoMSCheahWLLwinS, et al.Understanding the Relationship between Atherogenic Index of Plasma and Cardiovascular Disease Risk Factors among Staff of an University in Malaysia. J Nutr Metab2018; 2018.
27.
RadMRDabaghiGGDaroueiB, et al.The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: a systematic review and meta-analysis. Cardiovasc Diabetol2024; 23: 2–11.
28.
AkbariRadMDarroudiSFarsiF, et al.Investigation of the relationship between atherogenic index, anthropometric characteristics, and 10-year risk of metabolic syndrome: a population-based study. Ir J Med Sci2024; 1: 1–6.
29.
RocaRG. Atherogenic risk indicators as predictors of metabolic syndrome in a population in the sifontes municipality of Bolivar State Venezuela. Saber2016; 28.
30.
Kammar-GarcíaALópez-MorenoPHernández-HernándezME, et al.Atherogenic index of plasma as a marker of cardiovascular risk factors in Mexicans aged 18 to 22 years. Baylor Univ Med Cent Proc2021; 34: 22–27.
31.
AdlerAAgodoaLAlgraA, et al.Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet2021; 397: 1625–1636.
32.
MillánJPintóXMuñozA, et al.Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag2009; 5: 757–765.
